Medicinal active agents are based on the universal concept of target recognition. Their history is characterized by a limited number of revolutionary advances. The Paul Ehrlich ‘lock and key’ ...

Naked siRNA is easily degraded by nucleases in blood, and its relatively high molecular weight, negative charge, and hydrophilicity make it difficult to penetrate cell membranes. siRNA tends to ...

However, siRNA's therapeutic potential is limited by off-target effects, which occur when the siRNAs interact with non-target mRNA strands. These unintended interactions can lead to harmful ...

siRNA therapies show promise for treating diseases like cancer and genetic disorders, but their effectiveness depends on proper delivery. A recent study found that the method of mixing siRNA with ...

The biotechnology companies formed an alliance applying artificial intelligence to small interfering RNA therapeutic ...